8
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T1159 | Leflunomide | SU101,RS-34821,HWA486 | Others , Dehydrogenase , AhR |
Leflunomide (HWA486) is an immunomodulatory agent used in the therapy of rheumatoid arthritis and psoriatic arthritis. | |||
T12438 | PfDHODH-IN-1 | Dehydrogenase , Parasite | |
PfDHODH-IN-1 is an analogue of the active Leflunomide metabolite, has antimalarial activity. | |||
T11020 | DHODH-IN-11 | Dehydrogenase , DNA/RNA Synthesis | |
DHODH-IN-11 is a leflunomide derivative and weak dihydroorotate dehydrogenase (DHODH) inhibitor with a pKa of 5.03. | |||
T11021 | DHODH-IN-12 | Dehydrogenase | |
DHODH-IN-12 is a leflunomide derivative and a weak dihydrorotate dehydrogenase (DHODH) inhibitor with a pKa of 5.07. | |||
T7534 | Teriflunomide | A 77-1726 | Others |
Teriflunomide (A 77-1726) is the principal active metabolite of leflunomide, an approved therapy for rheumatoid arthritis and multiple sclerosis. | |||
T35150 | X 910279 | MNA-279,X91 0279,HMR 279,HMR 1279,MNA 279 | |
X 910279 is a leflunomide analog and a malononitrilamide. | |||
T11547 | HDHODH-IN-2 | Others | |
hDHODH-IN-2 is an analogue of the active metabolite of Leflunomide. hDHODH-IN-2 is a human dihydroorotate dehydrogenase (hDHODH) inhibitor with anti-inflammatory activity. | |||
T11813 | Laflunimus | HR325 | Others |
Laflunimus suppresses immunoglobulin (Ig) secretion, with IC50 values of 2.5 and 2 μM for IgM and IgG, respectively. Laflunimus also is a prostaglandin endoperoxide H synthase (PGHS) -1 and -2 inhibitor. Laflunimus is a... |